Seres Therapeutics
MCRB
#9876
Rank
โ‚ฌ65.53 M
Marketcap
6,77ย โ‚ฌ
Share price
-2.52%
Change (1 day)
-25.36%
Change (1 year)

EPS for Seres Therapeutics (MCRB)

EPS in 2025 (TTM): 12,79ย โ‚ฌ

According to Seres Therapeutics's latest financial reports the company's current EPS (TTM) is 12,29ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of N/A an increase over its 2023 EPS that were of -15,56ย โ‚ฌ.

EPS history for Seres Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)12,79ย โ‚ฌ
2024N/A-100%
2023-15,56ย โ‚ฌ-61.47%
2022-40,40ย โ‚ฌ220.83%
2021-12,59ย โ‚ฌ-35.71%
2020-19,59ย โ‚ฌ-9.68%
2019-21,69ย โ‚ฌ-48.97%
2018-42,50ย โ‚ฌ9.95%
2017-38,65ย โ‚ฌ-3.91%
2016-40,22ย โ‚ฌ-1.29%
2015-40,75ย โ‚ฌ285.48%
2014-10,57ย โ‚ฌ157.99%
2013-4,10ย โ‚ฌ42.44%
2012-2,88ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Xencor
XNCR
-1,55ย โ‚ฌ-112.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Agios Pharmaceuticals
AGIO
-6,08ย โ‚ฌ-149.43%๐Ÿ‡บ๐Ÿ‡ธ USA